NCT00628589View on ClinicalTrials.gov

Staccato Loxapine in Agitated Patients With Schizophrenia

PHASE3CompletedINTERVENTIONAL
Enrollment

344

Participants

Timeline

Start Date

February 29, 2008

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Patients With Schizophrenia and Acute Agitation
Interventions
DRUG

Inhaled loxapine 5 mg

Inhaled loxapine 5 mg

DRUG

Inhaled loxapine 10 mg

Inhaled loxapine 10 mg

DRUG

Inhaled placebo

Inhaled placebo

Trial Locations (1)

30308

Atlanta Center for Medical Research, Atlanta

Sponsors
All Listed Sponsors
lead

Alexza Pharmaceuticals, Inc.

INDUSTRY

NCT00628589 - Staccato Loxapine in Agitated Patients With Schizophrenia | Biotech Hunter | Biotech Hunter